The report states that medical cannabis makes up the biggest part of the market segment, taking up most of the revenue shares based on 2019 figures at 71%. This is attributed to the increasing adoption of cannabis as a legitimate alternative to pharmaceuticals, especially for treating life-threatening conditions including cancer, Parkinson’s disease, Alzheimer’s disease, arthritis, and neurological disorders among others. There is also a rising demand for effective painkillers as well as chronic pain medications for the elderly, and this is where much product demand is expected to be seen.
A new survey conducted by Pew Research examined what is considered “morally acceptable” in 25 countries.…
The agency has quietly sent a CBD compliance and enforcement policy to the White House…
When renowned US film director Paul Thomas Anderson and production designer Florencia Martin visited the…
A new chapter has begun for Chilean politics. After defeating candidate Jeannette Jara in the…
What it became is one of the most consequential cannabis-related cases the Supreme Court has…
Cannabis moves fast. New strains appear every season, each promising louder flavors, bigger yields, or…